Clinical Trial Update: The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

View source ↗

Summary

This clinical trial update describes a study investigating early prediction of bronchopulmonary dysplasia using volatile organic compounds, airway mucins, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Bronchopulmonary Dysplasia | Status: RECRUITING